» Articles » PMID: 16021544

[Correlation of MRI and Histopathology of Bone Marrow in Patients with Multiple Myeloma]

Overview
Journal Rofo
Publisher Thieme
Date 2005 Jul 16
PMID 16021544
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare MRI findings and histological plasmacellular infiltration of the bone marrow in patients with multiple myeloma (MM).

Material And Methods: Twenty-four patients with different stages of MM underwent 1.5T MRI of the pelvic bone before iliac crest punch biopsy. Precontrast T1wSE and STIR and postcontrast (Gd-DTPA) T1wSE-fatsat were acquired using axial slices. Immediately after the biopsy, T1wSE was repeated to locate the biopsy canal. The corresponding region in the examination before punch biopsy was assessed for bone marrow involvement using a three-point score (0: negative, 1: suspect, 2: definite).

Results: Two patients were not included because the location of the biopsy canal was unclear. Of 7 patients without histological plasmacellular infiltration, MRI was false positive in one case (suspect). Of 15 patients with histological infiltration, MRI was positive in 10 cases (4 suspect, 6 definite). The T1wSE was positive in 9 cases, STIR in 8 cases, and postcontrast T1wSE-fatsat in 7 cases. In 10 of the 15 patients, the infiltration was histologically graded as low (5 - 20 % of bone marrow). In this group, MRI was only positive in 5 cases (3 suspect, 2 definite). Of five patients with the infiltration histologically graded as high (> 20 % of bone marrow), MRI was positive in all cases (1 suspect, 4 definite).

Conclusion: Only advanced bone marrow infiltration in MM can be reliably detected by MRI. None of the used sequences proved to be significantly superior or inferior.

Citing Articles

Systemic mastocytosis revisited with an emphasis on skeletal manifestations.

Leone A, Criscuolo M, Gulli C, Petrosino A, Bianco N, Colosimo C Radiol Med. 2020; 126(4):585-598.

PMID: 33242205 DOI: 10.1007/s11547-020-01306-8.


Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy.

Ekert K, Hinterleitner C, Baumgartner K, Fritz J, Horger M Cancers (Basel). 2020; 12(3).

PMID: 32213834 PMC: 7140042. DOI: 10.3390/cancers12030761.


Multimodal imaging of bone metastases: From preclinical to clinical applications.

Ellmann S, Beck M, Kuwert T, Uder M, Bauerle T J Orthop Translat. 2018; 3(4):166-177.

PMID: 30035055 PMC: 5986987. DOI: 10.1016/j.jot.2015.07.004.


Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.

Sommer G, Klarhofer M, Lenz C, Scheffler K, Bongartz G, Winter L Eur Radiol. 2010; 21(4):857-62.

PMID: 20853109 DOI: 10.1007/s00330-010-1950-0.


Imaging response to systemic therapy for bone metastases.

Bauerle T, Semmler W Eur Radiol. 2009; 19(10):2495-507.

PMID: 19468736 DOI: 10.1007/s00330-009-1443-1.